The frequency of CD73+ Tregs, in contrast to that of CD39, was higher in Mild Recovered volunteers who had developed myalgia and arthralgia in the acute phase of the disease, suggesting differential ectonucleotidase modulation in the face of musculoskeletal symptoms. This evidence concerns the gene NT5E and Myalgia.